
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
LEO Pharma and Veeva Systems have announced a strategic technology partnership to enable scalable digital trials that are patient-centric and paperless. LEO Pharma will utilize the integrated suite of Veeva clinical products, including eTMF, CTMS, CDMS, Site Connect, eConsent, ePRO, Virtual Visits, and eSource.
By adopting technology and business processes, LEO Pharma hopes to achieve the following:






